BioCryst Pharmaceuticals Inc (BCRX)
Healthcare
Drug Manufacturers - Specialty & Generic
8.80 $
-1.9%
vs. previous close
Closing price · As of: 3. Aug 2026
BioCryst Pharmaceuticals Inc (BCRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -62 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19 | -20 | -8.9 | -54 | -1.4 | 8.2 | -5.2 | -28 | 41 | 42 | 276 | -62 | 297 | |
| 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 4.0 | 1.1 | 5.8 | |
| 13 | 12 | 16 | 14 | 13 | 17 | 21 | 21 | 21 | 19 | 73 | 16 | 129 | |
| 42 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -6.6 | -16 | 18 | -49 | -18 | -9.1 | -11 | -62 | 2.4 | -1.4 | 4.2 | -71 | -66 | |
| 0.5 | 1.0 | 0.6 | 0.2 | 0.2 | 0.1 | 0.7 | 0.1 | 0.2 | 1.3 | 0.8 | 0.4 | 2.7 | |
| -19 | 23 | -28 | 29 | -2.4 | 8.5 | 18 | 27 | 29 | 14 | -83 | -269 | -309 | |
| 2.0 | – | -2.2 | – | – | – | – | – | – | – | – | – | – | |
| 27 | – | – | – | – | -0.6 | -0.4 | -0.5 | -70 | -47 | -185 | 400 | 98 | |
| 29 | 1.2 | -3.2 | -1.0 | -2.0 | 1.3 | -4.0 | 0.5 | -74 | -59 | -202 | 413 | 78 | |
| -8.8 | 4.7 | -40 | -26 | -5.9 | 19 | 7.3 | 0.6 | -17 | -3.9 | -83 | 83 | -21 | |
| -19 | -21 | -9.5 | -54 | -1.5 | 8.2 | -5.9 | -28 | 41 | 40 | 275 | -63 | 294 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.